Open Evidence, together with 40 leading partners from civil society, academia and industry in 15 countries, has joined forces to develop novel, patient-focussed healthcare information tools to offer citizens timely access to information on medicines through the new IMI JU2 project Gravitate Health “Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment”. The project, which will be coordinated by the University of Oslo and leaded by Pfizer, will last 5 years and count with a budget of 18,5M€.
Gravitate-Health will develop and test an integrated, digital, user-centric health information solution seeking to demonstrate tangible improvements in availability and understanding of health information from a set of trusted sources, starting with regulator-approved medicinal product information and the Electronic Health Record International Patient Summary (EHR-IPS). The main outputs will be an open source digital platform supporting G-Lens functionally, and a White Paper with recommendations on realistic strategies to strengthen access, understanding and future use of digital services like electronic product information (ePI) as a tool for risk minimization.
Open Evidence will contribute on the tasks related to evaluation methodology and testing with both small and large scales to demonstrate the Gravitate health principles and objectives. Having an active role across different WPs, Open Evidence will lead T6.5 “Monitoring and Modelling G-lens impact” which will evaluate efficiency and effectiveness to determine whether Gravitate Health has improved adherence, health outcomes and quality of life, based on continuously collected data through the technology and self-reported measurements. It will produce a robust and coherent monitoring system to assess impact. This task will estimate the health and economic outcomes using the European Commission’s MAFEIP tool to measure the likelihood that the interventions will achieve their expected impacts in terms of increased efficiency and improved health and quality of life.